9 results
dm2 summary dpp4 management medications sglt2 agonists cardiology ddi diabetic diagnosis diuretics dosing drugdrug eudka euglycemic glp1 herbal interactions ketoacidosis
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... failure Common Side Effects ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... include side effects ... Side effects include ... #Pharmacology # ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
titrate up to effects ... only few side effects ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Summary of Diuretic Agents Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction CARBONIC ANHYDRASE
Agents Subclass, Drug ... Mechanism of Action, Effects ... others SGLT2 INHIBITORS ... #Medications #Pharmacology ... #summary #table
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... ) Common Side Effects ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Euglycemic Diabetic ... (EuDKA) SGLT2 Inhibitors ... Significant Adverse Drug ... Effects Definition ... diagnosis #management #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Ozempic), or daily tablet ... pancreatitis Common Side Effects ... Toxicities: • Gl side effects ... #Summary #DM2 #diabetes ... #endocrinology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products Angiotensin-Converting Enzyme Inhibitors (ACEIs) • Night-blooming
Cardiovascular Drug-Drug ... Angiotensin-Converting Enzyme Inhibitors ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
to remain stable ... upset as a side effect ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
No results found for "infectiousdiseases micro cdc algorithm ddx diagnosis hiv tick treatment ixodestick fungal id differential mite eschar africae akari fever rash febrile orientia parkeri"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #infectiousdiseases #micro #cdc #algorithm #ddx #diagnosis #hiv #tick #treatment #ixodestick #fungal #id #differential #mite #eschar #africae #akari #fever #rash #febrile #orientia #parkeri